Target intelligence / Profile preview

Acyl-CoA synthetase long chain family member 4 mRNA 3' untranslated region (ACSL4 mRNA 3' UTR)

Target
ACSL4 mRNA 3' UTR
Molecular classification
RNA, Untranslated region
01

Overview

The 3' untranslated region (UTR) of the Acyl-CoA synthetase long chain family member 4 (ACSL4) mRNA is a critical regulatory element that controls the expression of the ACSL4 enzyme (PMID: 32864145). ACSL4 plays a pivotal role in ferroptosis, a form of regulated cell death, by facilitating the incorporation of long-chain polyunsaturated fatty acids into phospholipids (Nature Chemical Biology, 2017). The 3' UTR contains binding sites for various microRNAs, such as miR-211-5p, miR-424-5p, and miR-199a-5p, which modulate mRNA stability and translation efficiency (PMID: 33061145, PMID: 31484324). In many cancers, dysregulation of these regulatory interactions leads to ACSL4 overexpression, which can either promote or suppress tumor growth depending on the context of ferroptosis sensitivity. Therapeutic strategies targeting this region, such as antisense oligonucleotides or miRNA mimics, aim to precisely tune ACSL4 levels to treat malignancies or protect tissues from oxidative damage. Consequently, the ACSL4 mRNA 3' UTR represents a significant target for precision medicine in oncology and metabolic diseases.

Other names
Long-chain-fatty-acid--CoA ligase 4 mRNA 3' UTRACSL4 3'-UTRFACL4 mRNA 3' UTRACS4 mRNA 3' UTRLACS4 mRNA 3' UTR
02

Mechanism of action

Binding to the 3' untranslated region to induce mRNA degradation or inhibit translation, thereby reducing ACSL4 protein expression and suppressing ferroptosis.

03

Biological functions

Regulation of mRNA stabilityTranslation regulationFerroptosis regulationLipid metabolismFatty acid activation
04

Disease associations

CancerHepatocellular carcinomaBreast cancerOvarian cancerNeurodegenerative diseaseIschemia-reperfusion injury
05

Safety considerations

Off-target RNA bindingImmune activation by synthetic oligonucleotidesPotential for systemic metabolic disruptionTissue-specific delivery challenges
06

Interacting drugs

miR-211-5p

3 more in the full profile.

07

Biomarkers

ACSL4 protein expressionLipid peroxidation levelsMalondialdehyde (MDA) levelsGlutathione peroxidase 4 (GPX4) levels

Beyond the preview

Go deeper on Acyl-CoA synthetase long chain family member 4 mRNA 3' untranslated region (ACSL4 mRNA 3' UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acyl-CoA synthetase long chain family member 4 mRNA 3' untranslated region (ACSL4 mRNA 3' UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call